Research Nester released a report titled “Non-Invasive Prenatal Testing Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global non-invasive prenatal testing market in terms of market segmentation by product, by application, by end user and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
Non-invasive prenatal testing is a screening test that helps in the detection of any abnormalities or birth defects that might be present in the fetus. The market for non-invasive prenatal testing is estimated to grow by a CAGR of 12.80% during the forecast period, i.e., 2020-2027. The market value is predicted to reach USD 6,406.77 million by 2027 from a value of USD 2,168.79 million in 2018. The market is segmented by product, by application, by end user and by region, out of which, the product segment is further segmented into Elisa kits, next generation sequencing systems and microarray analysis. Out of these, the next generation sequencing systems segment is anticipated to witness the highest growth on account of it being an advanced method for genome sequencing as compared with others.
The global non-invasive prenatal testing market is segmented by regions into North America, Latin America, Europe, Asia-Pacific and Middle East and Africa. The markets in North America and Europe are estimated to hold substantially large shares as a result of changing environmental conditions which lead to the development of various genetic health disorders such as cancers.
The Growing Risk of Chromosomal Abnormalities to Drive the Market Growth
A major factor contributing towards the growth of non-invasive prenatal testing market is the risk of chromosomal abnormalities among children. The various disorders resulting from this, including Down syndrome, result in miscarriages as well as other serious heart issues at later stages. In order to detect and treat this at an early stage, there is a growing demand for non-invasive procedures for prenatal testing. However, the lack of knowledge about the offered screening and diagnostic tests for Down syndrome, especially NIPT, is anticipated to hinder the market growth.
This report also provides the existing competitive scenario of some of the key players of the global non-invasive prenatal testing market which includes company profiling of PerkinElmer Inc., Natera Inc., F. Hoffmann La Roche Ltd., Yourgene Health plc, BGI, Illumina Inc., Agilent Technologies Inc., Laboratory Corporation of America Holdings and Quest Diagnostics. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global non-invasive prenatal testing market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.